Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

Clinical trial NCT00019760 · COMPLETED

Trial details

NCT number: NCT00019760
Sponsor: National Institutes of Health Clinical Center (CC)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Colon Cancer Liver Metastases Stage IV Rectal Cancer Recurrent Rectal Cancer Stage IV Colon Cancer

Start date: 1999-04-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.